Raymond James & Associates Integra Lifesciences Holdings Corp Transaction History

Raymond James & Associates

  • $146 Billion
  • Q1 2024

A detailed history of Raymond James & Associates transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Raymond James & Associates holds 228,599 shares of IART stock, worth $6.57 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
228,599
Previous 207,228 10.31%
Holding current value
$6.57 Million
Previous $9.02 Million 10.21%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024
BUY
$33.4 - $45.2 $713,791 - $965,969
21,371 Added 10.31%
228,599 $8.1 Million
Q4 2023

Jan 16, 2024
BUY
$34.21 - $44.59 $99,311 - $129,444
2,903 Added 1.42%
207,228 $9.02 Million
Q3 2023

Oct 24, 2023
BUY
$37.8 - $45.97 $1.72 Million - $2.09 Million
45,554 Added 28.69%
204,325 $7.8 Million
Q2 2023

Jul 25, 2023
BUY
$37.95 - $58.98 $3.31 Million - $5.14 Million
87,108 Added 121.55%
158,771 $6.53 Million
Q1 2023

Apr 14, 2023
BUY
$52.61 - $60.49 $321,710 - $369,896
6,115 Added 9.33%
71,663 $4.11 Million
Q4 2022

Feb 08, 2023
BUY
$42.17 - $58.6 $934,107 - $1.3 Million
22,151 Added 51.04%
65,548 $3.68 Million
Q3 2022

Oct 25, 2022
BUY
$42.28 - $57.17 $48,833 - $66,031
1,155 Added 2.73%
43,397 $1.84 Million
Q2 2022

Aug 12, 2022
BUY
$53.86 - $66.52 $96,140 - $118,738
1,785 Added 4.41%
42,242 $2.28 Million
Q1 2022

May 11, 2022
BUY
$62.86 - $69.24 $501,057 - $551,912
7,971 Added 24.54%
40,457 $2.6 Million
Q4 2021

Feb 08, 2022
SELL
$62.47 - $73.25 $5.5 Million - $6.45 Million
-88,022 Reduced 73.04%
32,486 $2.18 Million
Q3 2021

Nov 02, 2021
BUY
$64.97 - $76.19 $198,808 - $233,141
3,060 Added 2.61%
120,508 $8.25 Million
Q2 2021

Aug 11, 2021
BUY
$66.79 - $76.63 $124,630 - $142,991
1,866 Added 1.61%
117,448 $8.02 Million
Q1 2021

May 14, 2021
BUY
$62.63 - $71.15 $1.56 Million - $1.78 Million
24,987 Added 27.58%
115,582 $7.99 Million
Q4 2020

Feb 12, 2021
BUY
$43.31 - $66.55 $227,204 - $349,121
5,246 Added 6.15%
90,595 $5.88 Million
Q3 2020

Nov 04, 2020
BUY
$43.33 - $51.72 $730,543 - $871,999
16,860 Added 24.62%
85,349 $4.03 Million
Q2 2020

Jul 28, 2020
BUY
$41.42 - $55.57 $116,804 - $156,707
2,820 Added 4.29%
68,489 $3.22 Million
Q1 2020

Apr 21, 2020
SELL
$36.67 - $61.04 $125,044 - $208,146
-3,410 Reduced 4.94%
65,669 $2.93 Million
Q4 2019

Feb 12, 2020
BUY
$55.73 - $62.49 $718,192 - $805,308
12,887 Added 22.93%
69,079 $4.03 Million
Q3 2019

Nov 07, 2019
SELL
$53.29 - $64.59 $48,653 - $58,970
-913 Reduced 1.6%
56,192 $3.38 Million
Q2 2019

Aug 06, 2019
BUY
$46.45 - $55.85 $19,276 - $23,177
415 Added 0.73%
57,105 $3.19 Million
Q1 2019

May 06, 2019
BUY
$42.97 - $57.33 $1,804 - $2,407
42 Added 0.07%
56,690 $3.16 Million
Q4 2018

Feb 11, 2019
BUY
$42.62 - $64.51 $145,419 - $220,108
3,412 Added 6.41%
56,648 $2.56 Million
Q3 2018

Nov 14, 2018
BUY
$57.63 - $65.87 $236,859 - $270,725
4,110 Added 8.37%
53,236 $3.51 Million
Q2 2018

Aug 14, 2018
BUY
$54.05 - $67.23 $219,929 - $273,558
4,069 Added 9.03%
49,126 $3.16 Million
Q1 2018

May 14, 2018
SELL
$46.55 - $57.38 $1.2 Million - $1.48 Million
-25,812 Reduced 36.42%
45,057 $2.49 Million
Q4 2017

Feb 14, 2018
SELL
$46.22 - $51.77 $61,703 - $69,112
-1,335 Reduced 1.85%
70,869 $3.39 Million
Q3 2017

Nov 13, 2017
BUY
$47.8 - $53.63 $937,453 - $1.05 Million
19,612 Added 37.29%
72,204 $3.65 Million
Q2 2017

Aug 14, 2017
BUY
N/A
52,592
52,592 $2.87 Million

Others Institutions Holding IART

# of Institutions
294
Shares Held
69.9M
Call Options Held
20.2K
Put Options Held
9.3K
View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

IART Quotes by TradingView
  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $2.4B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email